241 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
IONS Ionis Pharmaceuticals, Inc. $48.21 $6.62B N/A
Article Searches
Akcea and Ionis Confirm Positive Trial Results for Hypertriglyceridemia Treatment https://www.fool.com/investing/2020/01/28/akcea-and-ionis-confirm-positive-phase-2-trial-res.aspx?source=iedfolrf0000001 Jan 28, 2020 - Both primary as well as multiple secondary endpoints were met in the trial.
5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals https://www.fool.com/investing/2020/01/16/5-reasons-2020-will-be-a-big-year-for-ionis-pharma.aspx?source=iedfolrf0000001 Jan 16, 2020 - Investors are overly focused on one issue with this stock while the company is making progress on many fronts.
Ionis Pharmaceuticals, Inc. (IONS) CEO Brett Monia Presents at 38th Annual J.P. Morgan Healthcare Conference (Transcript) https://seekingalpha.com/article/4317024-ionis-pharmaceuticals-inc-ions-ceo-brett-monia-presents-38th-annual-j-p-morgan-healthcare?source=feed_sector_transcripts Jan 15, 2020 -
ION Geophysical CFO Bate set to depart https://seekingalpha.com/news/3528644-ion-geophysical-cfo-bate-set-to-depart?utm_source=feed_news_all&utm_medium=referral Dec 27, 2019 - ION Geophysical (NYSE:IO) says Executive VP and CFO Steve Bate will retire from the company, effective Feb. 1.17-year company veteran Mike Morrision will become interim CFO after holding various senio
ProQR (PRQR) Begins Dosing in Phase I/II Eye Disorder Study http://www.zacks.com/stock/news/667736/proqr-prqr-begins-dosing-in-phase-i-ii-eye-disorder-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-667736 Dec 12, 2019 - ProQR (PRQR) doses the first patient in the phase I/II Aurora study on QR-1123, which is being evaluated for treating patients with autosomal dominant retinitis pigmentosa.
Gates, Bezos bet on flow battery technology, a potential rival to big bets on lithium-ion https://www.cnbc.com/2019/12/10/tesla-gm-bet-big-on-lithium-ion-but-gates-bezos-fund-flow-battery.html Dec 10, 2019 - Elon Musk and GM are making big bets on lithium-ion battery technology for energy storage and auto markets in the climate change era, but iron-flow batteries, which are backed by Bill Gates, Jeff Bezos, Jack Ma and Michael Bloomberg, could play a big role in the future.
Surging Earnings Estimates Signal Upside for Ionis Pharmaceuticals (IONS) Stock http://www.zacks.com/stock/news/629343/surging-earnings-estimates-signal-upside-for-ionis-pharmaceuticals-ions-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-629343 Nov 20, 2019 - Ionis Pharmaceuticals (IONS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Master plan for Ion and Innovation District at former Midtown Sears site revealed https://www.chron.com/business/prime-property/article/The-Ion-former-Midtown-Sears-and-Innovation-14826265.php Nov 11, 2019 -

Documents filed with the city show a proposed site plan for the Ion and 15-acre South Main Innovation District comprising multiple blocks along and east of Main Street. The plan shows 13 proposed new structures, greenspace and a "Central Laneway" stretching from Main to Caroline.

Ionis Pharmaceuticals, Inc. (IONS) Q3 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/11/06/ionis-pharmaceuticals-inc-ions-q3-2019-earnings-ca.aspx?source=iedfolrf0000001 Nov 06, 2019 - IONS earnings call for the period ending September 30, 2019.
Ionis Pharmaceuticals, Inc. (IONS) CEO Stanley Crooke on Q3 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4303447-ionis-pharmaceuticals-inc-ions-ceo-stanley-crooke-q3-2019-results-earnings-call-transcript?source=feed_sector_healthcare Nov 06, 2019 - Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2019 Earnings Conference Call November 6, 2019 11:30 A.M. ET Company Participants Wade Walke - Vice President, Investor Relations Stan Crow - Chairman of t

Pages: 123456...25

Page 1>